Onesource Specialty Pharma Limited (ONESOURCE) Share Analysis
NSE · Healthcare · Healthcare
Onesource Specialty Pharma Limited (NSE: ONESOURCE) is an Indian listed company in the Healthcare sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 14 Nov 2026, the share price was ₹1,610.00, P/E 1,614, ROE -1.09%.
Get the AI verdict on ONESOURCE: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
ONESOURCE chart with trendlines
Is ONESOURCE a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Onesource Specialty Pharma Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
ONESOURCE key facts
| Price and valuation | |
|---|---|
| Share price | ₹1,610.00 |
| Market cap | ₹18,464 Cr |
| P/E ratio | 1,614 |
| P/B ratio | 3.12 |
| EPS | ₹-0.15 |
| Book value per share | ₹516.00 |
| Dividend yield | 0% |
| 52-week range | |
| 52-week high | ₹1,917.80 |
| 52-week low | ₹1,057.00 |
| Face value | ₹1.00 |
| Shareholding pattern | |
| Promoters | 30.47% |
| FIIs | 19.45% |
| DIIs | 24.2% |
| Public | 25.86% |
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.